Decision Making in Prostate-Specific Antigen Screening

This publication has 95 references indexed in Scilit:

• Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
  New England Journal of Medicine, 2005
• THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?
  Journal of Urology, 2004
• Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker
  Cancer, 2004
• Prostate-specific antigen test use reported in the 2000 National Health Interview Survey
  Preventive Medicine, 2004
• Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
  New England Journal of Medicine, 2004
• Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer
  JNCI Journal of the National Cancer Institute, 2003
• Screening for prostate cancer
  The Lancet, 2003
• Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
  Annals of Internal Medicine, 2002
• The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
  Published by Elsevier ,2001
• Localised prostatic cancer: management and detection issues
  The Lancet, 1994